Telomir Pharmaceuticals engages Andriy Mushak as fractional CFO
Telomir Pharmaceuticals has entered into a consulting agreement with Andriy Mushak to serve as fractional chief financial officer effective June 6, 2026, providing senior financial leadership for SEC compliance, audit readiness, and capital markets support. The engagement strengt
View filing at SEC.gov →